EUVIMEDEUVIMED entdecken
Open Access

Phosphorylated Analogs of Paracetamol and Their Anti‐Inflammatory Potential

Osvaldo León de la Cruz, Gabriel Alfonso Gutiérrez-Rebolledo iD, Carlos Zepactonal Gómez Castro iD, Ángel Daniel Campos Juárez iD, Porfirio Alonso Ruiz-Hurtado iD, Josué Rodríguez-Lozada iD, José Luis Castrejón-Flores iD, María Guadalupe Ramírez-Sotelo iD, Marco Franco-Pérez iD, Angel Zamudio-Medina iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Osvaldo León de la Cruz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Politécnico Nacional, Unidad Profesional Interdisciplinaria de Biotecnología, Mexico City, Mexico. Hauptthemen laut MEDLINE: Acetaminophen, Edema, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paracetamol is a widely used analgesic and antipyretic agent; however, its use is limited by minimal anti‐inflammatory activity and the risk of hepatotoxicity from prolonged oral use or in acute overdose. To address these limitations, four novel phosphorylated paracetamol analogs (2a–2d) were synthesized via a UV‐radical methodology and evaluated through integrated in silico, in vitro, and in vivo for anti‐inflammatory dermal approaches. Molecular docking suggested plausible binding interactions with COX‐1 and COX‐2 for all analogs. In vitro cytotoxicity assays in THP‐1 cells showed that 2a and 2b did not affect cell viability at 100 μM over 24 h. In a TPA‐induced acute ear edema model in CD1 male mice, 2a produced about 50% inhibition of edema at the lowest tested quantity (0.5 mg/ear), representing a fourfold potency advantage over indomethacin at the same amount, while 2b displayed significant anti‐inflammatory and vasoregulatory activity at higher quantities. Computational ADME profiling indicated that all analogs satisfy Lipinski’s drug‐likeness criteria and exhibit low predicted hERG channel risk. These results support N‐phosphorylation of 4‐aminophenol as a viable strategy to improve the topical anti‐inflammatory efficacy of paracetamol analogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenEdemaAnti-Inflammatory Agents, Non-SteroidalAnimalsHumansPhosphorylationMaleMiceCyclooxygenase 1Cyclooxygenase 2Molecular Docking SimulationStructure-Activity RelationshipCell SurvivalMolecular StructureDose-Response Relationship, DrugTetradecanoylphorbol Acetate

Stichwörter der Autor:innen

TPA modelanti‐inflammatory activitycyclooxygenase enzyme inhibitionparacetamolphosphorylated paracetamol analogs

Substanzen

AcetaminophenAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 1Cyclooxygenase 2Tetradecanoylphorbol Acetate

Autor:innen und Institutionen

  • Instituto Politécnico Nacional, Unidad Profesional Interdisciplinaria de Biotecnología, Mexico City, Mexico.
  • Laboratorio de Toxicología Productos Naturales, Departamento Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
  • SECIHTI, Universidad Autónoma del Estado de Hidalgo, Mineral de La Reforma, Hidalgo, México.
  • Laboratorio de Toxicología Molecular, Departamento Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
  • Universidad Politécnica de Tlaxcala, Tepeyanco, Tlaxcala, México.
  • Departamento de Física y Química Teórica, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, México.

ORCID-Profile: Gabriel Alfonso Gutiérrez-Rebolledo, Carlos Zepactonal Gómez Castro, Ángel Daniel Campos Juárez, Porfirio Alonso Ruiz-Hurtado, Josué Rodríguez-Lozada, José Luis Castrejón-Flores, María Guadalupe Ramírez-Sotelo, Marco Franco-Pérez, Angel Zamudio-Medina

Zitieren

APA

Cruz, O. L., Gutiérrez-Rebolledo, G. A., Castro, C. Z. G., Juárez, Á. D. C., Ruiz-Hurtado, P. A., Rodríguez-Lozada, J., Castrejón-Flores, J. L., Ramírez-Sotelo, M. G., Franco-Pérez, M., & Zamudio-Medina, A. (2026). Phosphorylated Analogs of Paracetamol and Their Anti‐Inflammatory Potential. ChemMedChem. https://doi.org/10.1002/cmdc.70469

Vancouver

Cruz OL, Gutiérrez-Rebolledo GA, Castro CZG, Juárez ÁDC, Ruiz-Hurtado PA, Rodríguez-Lozada J, et al. Phosphorylated Analogs of Paracetamol and Their Anti‐Inflammatory Potential. ChemMedChem. 2026. doi:10.1002/cmdc.70469

BibTeX
@article{Cruz2026,
  author = {Cruz, Osvaldo León de la and Gutiérrez-Rebolledo, Gabriel Alfonso and Castro, Carlos Zepactonal Gómez and Juárez, Ángel Daniel Campos and Ruiz-Hurtado, Porfirio Alonso and Rodríguez-Lozada, Josué and Castrejón-Flores, José Luis and Ramírez-Sotelo, María Guadalupe and Franco-Pérez, Marco and Zamudio-Medina, Angel},
  title = {Phosphorylated Analogs of Paracetamol and Their Anti‐Inflammatory Potential},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70469}
}
Kostenlos starten →